PubMed Central (PMC) Search Page
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1998 | 1 |
| 1999 | 2 |
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 22 |
| 2008 | 53 |
| 2009 | 62 |
| 2010 | 76 |
| 2011 | 100 |
| 2012 | 123 |
| 2013 | 139 |
| 2014 | 125 |
| 2015 | 148 |
| 2016 | 184 |
| 2017 | 192 |
| 2018 | 184 |
| 2019 | 177 |
| 2020 | 255 |
| 2021 | 249 |
| 2022 | 206 |
| 2023 | 214 |
| 2024 | 252 |
| 2025 | 222 |
| 2026 | 180 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Leukemia"[Journal]
3,176
results
Embargoed Articles:
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
The epigenetic state of the cell of origin defines mechanisms of leukemogenesis.
- Li Z, Fierstein S, Tanaka-Yano M, Frenis K, Chen CC, Wang D, Falchetti M, Côté P, Curran C, Lu K, Liu T, Orkin S, Li H, Lummertz da Rocha E, Hu S, Zhu Q, Rowe RG.
- Leukemia. Author manuscript. 2024 Oct 1;39(1):87-97. doi: 10.1038/s41375-024-02428-y.
- PMCID: PMC13677145
Li Z, et al.Leukemia. Author manuscript. 2024.PMCID: PMC13677145 -
Disturbances in microbial skin recolonization and cutaneous immune response following allogeneic stem cell transfer.
- Bayer N, Hausmann B, Pandey RV, Deckert F, Gail LM, Strobl J, Pjevac P, Krall C, Unterluggauer L, Redl A, Bachmayr V, Kleissl L, Nehr M, Kirkegaard R, Makristathis A, Watzenboeck ML, Nica R, Staud C, Hammerl L, Wohlfarth P, Ecker RC, Knapp S, Rabitsch W, Berry D, Stary G.
- Leukemia. Author manuscript. 2022 Oct 12;36(11):2705-2714. doi: 10.1038/s41375-022-01712-z.
- PMCID: PMC7619595
Bayer N, et al.Leukemia. Author manuscript. 2022.PMCID: PMC7619595 -
Chernobyl at 40 years: leukaemias, cancers and implications for nuclear safety.
- Gale RP.
- Leukemia. 2026 Aug 24;40(10):2127-2128. doi: 10.1038/s41375-026-03027-9.
- PMCID: PMC13612245
Gale RP.Leukemia. 2026.PMCID: PMC13612245 -
Next-generation synthetic trials in hematology with generative artificial intelligence.
- Eckardt JN, Bornhäuser M, Middeke JM.
- Leukemia. 2026 Aug 19;40(10):2129-2132. doi: 10.1038/s41375-026-03116-9.
- PMCID: PMC13612214
Eckardt JN, et al.Leukemia. 2026.PMCID: PMC13612214 -
Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms.
- Hertz C, Spyrou N, Hoffman R, Cimen Bozkus C, Bhardwaj N, Tremblay D, Kremyanskaya M, Mascarenhas J.
- Leukemia. 2026 Aug 18;40(10):2107-2117. doi: 10.1038/s41375-026-03115-w.
- PMCID: PMC13612213
Hertz C, et al.Leukemia. 2026.PMCID: PMC13612213 -
Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis.
- Mosnier C, Copin MC, Quintin-Roué I, Lippert E, Lu Y, Riou J, Blanchard S, Mérillon N, Pawlicki B, Boyer F, Argentin J, Sureau L, Malinge A, Sevestre J, Demoy M, Aubé C, Reboux N, Farhi J, Giltat A, Nunes Gomes C, Hunault M, Delneste Y, Ugo V, Ianotto JC, Orvain C, Luque Paz D.
- Leukemia. 2026 Aug 3;40(10):2309-2319. doi: 10.1038/s41375-026-03088-w.
- PMCID: PMC13612218
Mosnier C, et al.Leukemia. 2026.PMCID: PMC13612218 -
Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression.
- D'Souza C, Thio N, Zhu R, DeSilva H, Mempin M, Martelotto L, Semple T, Thompson E, Lade S, Magnusson M, Houseman N, Overstall S, Thorne H, Deva A, van der Weyden C, Blombery P, Prince HM, Neeson PJ.
- Leukemia. 2026 Jul 30;40(10):2283-2297. doi: 10.1038/s41375-026-03049-3.
- PMCID: PMC13612225
D'Souza C, et al.Leukemia. 2026.PMCID: PMC13612225 -
Invasive mold infection in pediatric acute lymphoblastic leukemia-a detailed analysis of the clinical trial AIEOP-BFM ALL2009.
- Lehrnbecher T, Cesaro S, Alten J, Attarbaschi A, Barbaric D, Bochennek K, Bodmer N, Conter V, Elitzur S, Möricke A, Schrappe M, Stary J, Zapotocka E, Zimmermann M, Groll AH.
- Leukemia. 2026 Jul 29;40(10):2355-2358. doi: 10.1038/s41375-026-03084-0.
- PMCID: PMC13612224
Lehrnbecher T, et al.Leukemia. 2026.PMCID: PMC13612224 -
Systematic profiling of AGO2-associated circRNAs and functional investigation reveal circN4BP2L2 as a survival-promoting regulator in T-ALL.
- Drobna-Sledzinska M, Buratin A, Roncaglia E, Caregari A, Glogovitis I, Kosmalska M, Zhao X, Bresolin S, Gaffo E, Van den Berg A, Kluiver J, Dawidowska M, Bortoluzzi S.
- Leukemia. 2026 Jul 27;40(10):2223-2235. doi: 10.1038/s41375-026-03033-x.
- PMCID: PMC13612239
Drobna-Sledzinska M, et al.Leukemia. 2026.PMCID: PMC13612239 -
Improved inter-lab precision after CML international scale adoption: a 15-year history of BCR::ABL1 proficiency testing.
- Kim AS, Long T, Oldridge DA, Jennings LJ, Ding Y, Vasalos P, Watt C, Press RD.
- Leukemia. 2026 Jul 27;40(10):2236-2243. doi: 10.1038/s41375-026-03062-6.
- PMCID: PMC13612228
Kim AS, et al.Leukemia. 2026.PMCID: PMC13612228